Company page

Heron Therapeutics, Inc.

Heron Therapeutics, Inc. (HRTX) is a public company based in the United States, focusing on innovative therapies for patients with serious medical conditions. The company has a market capitalization of approximately $79 million. Heron is dedicated to advancing its product pipeline to improve patient outcomes in pain management and other therapeutic areas.